Nuuron raises €3.5M Seed round
31 October 2024· Berlin, Germany· health, neurotech, ai, biotech, b2b, software_hardware
The funding will be used for animal studies in collaboration with the German Center for Neurodegenerative Diseases (DZNE), a clinical trial with Alzheimer's patients at Charité, product development, and market entry preparations in Europe and the U.S.
Investors
LeadHigh-Tech Gründerfonds
Also participating
IBB Venturescaesar.Business Angel Club BerlinRoX Health
About Nuuron
Stage
Seed
Headquarters
Berlin, Germany
Founded
2023
Team Size
6–20
Sectors
healthneurotechaibiotechb2bsoftware_hardware